摘要
目的探讨利巴韦林气雾剂与利巴韦林颗粒治疗小儿上呼吸道病毒性感染的疗效比较。方法选择2016年8月-2016年12月期间在商丘市第一人民医院儿科治疗的50例小儿上呼吸道病毒性感染患儿作为研究对象,随机将其分为观察组与对照组,每组各25例。对照组服用利巴韦林颗粒,观察组采用利巴韦林气雾剂治疗,比较两组治疗效果和不良反应发生率情况。结果观察组临床疗效较对照组好,差异有统计学意义(P<0.05);观察组不良反应低于对照组,差异有统计学意义(P<0.05)。结论利巴韦林气雾剂治疗小儿上呼吸道病毒性感染效果更好,不良反应少,安全性更高。
Objective To investigate the efficacy of ribavirin aerosol and ribavirin granules in the treatment of upper respiratory tract infection in children. Methods Fifty children with upper respiratory tract infection were treated with pediatric treatment in Shangqiu First People 's Hospital from August to December,2016,and were randomly divided into observation group and control group. 25 cases. The control group was treated with ribavirin granules. The observation group was treated with ribavirin aerosol,and the treatment effect and the incidence of adverse reactions were compared between the two groups. Results The clinical curative effect of the observation group was better than that of the control group( P<0. 05). The adverse effect of the observation group was lower than that of the control group( P<0. 05). Conclusion Ribavirin aerosol treatment of children with upper respiratory tract infection is better,less adverse reactions,higher safety.
